Infusion Pharmacy Ownership in 2026: The Legal Side of Infusion Pharmacy with Boesen & Snow Law
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Infusion Pharmacy Ownership in 2026: The Legal Side of Infusion Pharmacy with Boesen & Snow Law
-
ナレーター：
-
著者：
Send us Fan Mail
Schedule an Rx Assessment
Your infusion pharmacy is scaling fast, but is your legal foundation keeping up?
On this episode of the Bottom Line Pharmacy Podcast, we sit down with Chris Pucillo and Patrick Carpenter of Boesen & Snow Law to break down:
- Why home infusion pharmacies are consolidating in 2026, and what's driving it
- The state-by-state licensing patchwork that trips up new infusion clinics
- What regulatory and financial due diligence actually looks like when buying or selling an infusion pharmacy
- Where anti-kickback risk hides in doctor detailing and cash-pay pricing
And more!
Stay connected with Patrick Carpenter, Chris Pucillo and Boesen & Snow Law:
Patrick Carpenter LinkedIn
Chris Pucillo LinkedIn
Boesen & Snow Website
Boesen & Snow LinkedIn
Boesen & Snow Facebook
Stay connected with us:
Facebook
Scotty Sykes – CPA, CFP LinkedIn
Scotty Sykes – CPA, CFP Twitter
Bonnie Bond – CPA LinkedIn
Bonnie Bond – CPA Twitter
More resources on this topic:
Podcast - Peptides, Policy, and PBMs: 2026 Quarter 3 Pharmacy Update
Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24
Podcast – The Bottom Line Catch Up | Ep. 3 | R&D Tax Credit, Trump Accounts, Taylor Swift's Wedding